OMCL

$38.408.29%2.94

Omnicell Inc (OMCL)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$35.46

Aprire:

$36.54

Volume 24 ore:

250,895

Volume relativo:

0.34

Capitalizzazione di mercato:

$1.75B

Reddito:

$1.23B

Utile/perdita netta:

$20.43M

Rapporto P/E:

87.06

EPS:

$0.4411

Flusso di cassa netto:

$95.39M

1W Prestazione:

+6.82%

1M Prestazione:

+14.29%

6M Prestazione:

-11.60%

1Y Prestazione:

+11.30%

Intervallo 1D:

$36.54$39.48

Intervallo di 1 settimana:

$35.19$38.50

Portata 52W:

$31.75$55.00

Profilo aziendale di Omnicell Inc (OMCL)

Nome

Omnicell Inc

Settore

Healthcare

Industria

Health Information Services

Telefono

(877) 415-9990

Indirizzo

4220 NORTH FREEWAY, FORT WORTH, USA

Dipendente

3,580

@Omnicell

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di OMCL su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Omnicell Inc Azioni (OMCL) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-02-04	Aggiornamento	BofA Securities	Neutral → Buy
2026-01-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2025-05-14	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-10-31	Downgrade	BofA Securities	Buy → Neutral
2024-08-02	Aggiornamento	Barclays	Underweight → Equal Weight
2024-01-03	Iniziato	Barclays	Underweight
2023-11-03	Downgrade	BTIG Research	Buy → Neutral
2023-11-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-11-03	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2023-10-11	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-09-26	Reiterato	Wells Fargo	Underweight
2023-08-02	Downgrade	Piper Sandler	Overweight → Neutral
2023-07-20	Downgrade	Wells Fargo	Overweight → Underweight
2023-02-27	Aggiornamento	The Benchmark Company	Hold → Buy
2022-11-03	Downgrade	The Benchmark Company	Buy → Hold
2022-09-16	Iniziato	KeyBanc Capital Markets	Overweight
2022-09-09	Iniziato	BofA Securities	Buy
2022-07-15	Iniziato	SVB Leerink	Mkt Perform
2021-12-06	Resumed	Wells Fargo	Overweight
2021-06-09	Iniziato	JP Morgan	Neutral
2021-05-24	Iniziato	BTIG Research	Buy
2021-02-02	Aggiornamento	Piper Sandler	Neutral → Overweight
2020-12-08	Iniziato	Berenberg	Buy
2020-12-03	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2020-07-07	Iniziato	Stephens	Overweight
2020-02-07	Reiterato	Dougherty & Company	Buy
2019-11-21	Reiterato	Dougherty & Company	Buy
2019-07-26	Aggiornamento	Craig Hallum	Hold → Buy
2019-03-07	Reiterato	Dougherty & Company	Buy
2018-06-29	Resumed	The Benchmark Company	Buy
2017-09-05	Reiterato	The Benchmark Company	Buy
2017-07-28	Reiterato	Dougherty & Company	Buy
2017-04-21	Downgrade	Piper Jaffray	Overweight → Neutral
2017-01-19	Iniziato	Dougherty & Company	Buy
2016-12-06	Reiterato	The Benchmark Company	Buy
2016-07-07	Reiterato	FBR Capital	Outperform
2016-03-21	Reiterato	Topeka Capital Markets	Buy
2016-01-07	Iniziato	The Benchmark Company	Buy
2015-11-16	Reiterato	Topeka Capital Markets	Buy
2015-10-30	Reiterato	FBR Capital	Outperform
2015-09-28	Aggiornamento	Sidoti	Neutral → Buy
2015-07-31	Reiterato	Topeka Capital Markets	Buy

Omnicell Inc Azioni (OMCL) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	1,184.85	1,112.24	1,147.11	1,295.95	1,132.02
Cost of revenue USD (M)	681.40	641.24	650.27	706.96	577.37
Gross profit USD (M)	503.44	471.00	496.84	588.99	554.65
Research and development USD (M)	88.67	90.41	97.12	104.97	75.72
Operating expenses USD (M)	498.28	470.67	531.71	591.31	465.15
Operating income USD (M)	5.16	0.34	-34.87	-2.32	89.51
Income before tax USD (M)	11.33	25.59	-20.11	-2.45	66.01
Income tax expense USD (M)	9.27	13.06	0.26	-8.10	-11.84
Net income USD (M)	2.05	12.53	-20.37	5.65	77.85
Basic EPS USD/shares	0.04	0.27	-0.45	0.13	1.79
Diluted EPS USD/shares	0.04	0.27	-0.45	0.12	1.62
Basic weighted shares shares (M)	45.97	46.05	45.21	44.40	43.48
Diluted weighted shares shares (M)	46.36	46.26	45.21	45.89	47.94
Selling, general and administrative USD (M)	409.61	380.25	434.59	486.34	389.43

Omnicell Inc Azioni (OMCL) insider trading

Njoku NnamdiAug 17 '26
President & COO
Transazione
Sale
Costo
$36.85
#Azioni
3,083
Valore ($)
113,609
#Azioni Totale
161,224
Njoku NnamdiAug 17 '26
Officer
Transazione
Proposed Sale
Costo
$36.85
#Azioni
3,083
Valore ($)
113,609
#Azioni Totale
0
LIPPS RANDALL AJul 15 '26
CHAIRMAN, CEO
Transazione
Sale
Costo
$47.00
#Azioni
10,000
Valore ($)
470,000
#Azioni Totale
345,861
Randall LippsJul 15 '26
Officer
Transazione
Proposed Sale
Costo
$47.00
#Azioni
10,000
Valore ($)
470,000
#Azioni Totale
0
Manley Corey JMay 18 '26
Officer
Transazione
Proposed Sale
Costo
$43.22
#Azioni
5,025
Valore ($)
217,180
#Azioni Totale
0
Manley Corey JMay 18 '26
EVP&CHIEF LEGAL/ADMIN OFFICER
Transazione
Sale
Costo
$43.22
#Azioni
5,025
Valore ($)
217,180
#Azioni Totale
112,783
Njoku NnamdiMay 18 '26
EVP, Chief Operating Officer
Transazione
Sale
Costo
$43.22
#Azioni
3,090
Valore ($)
133,550
#Azioni Totale
154,785
Njoku NnamdiMay 18 '26
Officer
Transazione
Proposed Sale
Costo
$43.22
#Azioni
3,090
Valore ($)
133,550
#Azioni Totale
0
Manley Corey JMar 16 '26
EVP&CHIEF LEGAL/ADMIN OFFICER
Transazione
Sale
Costo
$34.69
#Azioni
7,405
Valore ($)
256,879
#Azioni Totale
96,717
Manley Corey JMar 16 '26
Officer
Transazione
Proposed Sale
Costo
$34.69
#Azioni
7,405
Valore ($)
256,879
#Azioni Totale
0

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Njoku Nnamdi	President & COO	Aug 17 '26	Sale	$36.85	3,083	113,609	161,224
Njoku Nnamdi	Officer	Aug 17 '26	Proposed Sale	$36.85	3,083	113,609	0
LIPPS RANDALL A	CHAIRMAN, CEO	Jul 15 '26	Sale	$47.00	10,000	470,000	345,861
Randall Lipps	Officer	Jul 15 '26	Proposed Sale	$47.00	10,000	470,000	0
Manley Corey J	Officer	May 18 '26	Proposed Sale	$43.22	5,025	217,180	0
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	May 18 '26	Sale	$43.22	5,025	217,180	112,783
Njoku Nnamdi	EVP, Chief Operating Officer	May 18 '26	Sale	$43.22	3,090	133,550	154,785
Njoku Nnamdi	Officer	May 18 '26	Proposed Sale	$43.22	3,090	133,550	0
Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Mar 16 '26	Sale	$34.69	7,405	256,879	96,717
Manley Corey J	Officer	Mar 16 '26	Proposed Sale	$34.69	7,405	256,879	0

Omnicell Inc Borsa (OMCL) Ultime notizie

Nov 03, 2026

BofA Securities Adjusts Price Target on Omnicell to $68 From $70 - marketscreener.com

Nov 03, 2026

Nov 02, 2026

Omnicell’s Q3 earnings call: our top 5 analyst questions - Yahoo Finance

Nov 02, 2026

Oct 30, 2026